Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Onconova Therapeutics Q3 EPS $(0.23) Beats $(0.29) Estimate, Sales $57.00K Miss $70.00K Estimate

Author: Benzinga Newsdesk | November 14, 2023 05:38pm
Onconova Therapeutics (NASDAQ:ONTX) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.29) by 20.69 percent. This is a 11.54 percent increase over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $57.00 thousand which missed the analyst consensus estimate of $70.00 thousand by 18.57 percent. This is the same as the same period last year.

Posted In: ONTX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist